The American College of Rheumatology (ACR) is an ethically-driven, professional membership organization committed to improving the care of patients with rheumatic disease and advancing the rheumatology subspecialty.
The Childhood Arthritis & Rheumatology Research Alliance–or CARRA–conducts collaborative research to prevent, treat and cure pediatric rheumatic diseases.
The Scleroderma Foundation is the national organization for people with scleroderma and their families and friends. Their mission is to provide support, education, and research to improve treatment and ultimately find the cause of and cure for scleroderma and related diseases.
Castle Creek Biosciences is honored to support these events:
Courtesy of Delaware Valley Chapter of the Scleroderma Foundation—”Stepping Out to Cure Scleroderma” Annual Philly Metro Walk. Used with permission.
The Scleroderma Research Foundation (SRF) is America’s largest nonprofit investor in scleroderma research. Patients and their loved ones find hope in the fact the SRF is dedicated exclusively to funding medical research that will help them live longer, fuller lives.
Rare Disease Day® occurs on the last day of February each year to raise global awareness of rare diseases. Learn more about this special day that honors those living with a rare disease and its impact on their lives.
NORD provides a unified voice for people battling rare diseases – those courageous individuals, and the parents and other caregivers seeking to help them, so that they won’t have to fight that battle alone.
Global Genes™ is one of the leading rare disease patient advocacy organizations in the world. Their mission is to build awareness, educate the global community, and provide critical connections and resources that equip advocates to become activists for their disease.
The EveryLife Foundation for Rare Diseases is a nonprofit dedicated to accelerating biotech innovation for rare disease treatments through science-driven public policy.
Castle Creek Biosciences is honored to support this event:
In response to unmet research needs in pediatric dermatology that require collaborative, multicenter efforts, dermatology leaders created the Pediatric Dermatology Research Alliance (PeDRA) in 2012. PeDRA is the research arm of the Society for Pediatric Dermatology.
Please note: The third-party sites listed on this page are for informational purposes only. Castle Creek Biosciences makes every effort to offer the most useful and accurate resources available to people living with epidermolysis bullosa; however, we do not endorse and are not responsible for the content found on these third-party websites.